Pulocimab
Product Specifications
UNSPSC Description
Pulocimab is an anti-VEGFR2 monoclonal antibody (mAb). Pulocimab can be used for the research of cancers[1].
Target Antigen
VEGFR
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pulocimab.html
Solubility
10 mM in DMSO
Smiles
[Pulocimab]
References & Citations
[1]Keam SJ. Cadonilimab: First Approval. Drugs. 2022 Aug;82(12):1333-1339.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99808/Pulocimab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99808/
Clinical Information
Phase 3
CAS Number
2428381-49-9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items